ADMA 16.87 ▼ -0.21% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ADMA Biologics Inc.

    NASDAQ: ADMA · Real-Time Price · USD
    16.87
    -0.04 (-0.21%)
    At close: Sep 05, 2025, 3:59 PM
    16.95
    0.47%
    After-hours: Sep 05, 2025, 07:39 PM EDT
    -0.21%
    Bid 16.69
    Market Cap 4.03B
    Revenue (ttm) 474.17M
    Net Income (ttm) 208.93M
    EPS (ttm) 0.85
    PE Ratio (ttm) 19.85
    Forward PE 18.58
    Analyst Strong Buy
    Ask 17.45
    Volume 2,749,916
    Avg. Volume (20D) 3,210,501
    Open 17.00
    Previous Close 16.91
    Day's Range 16.77 - 17.17
    52-Week Range 13.50 - 25.67
    Beta 0.53

    About ADMA

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol ADMA
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for ADMA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    ADMA Biologics Inc. is scheduled to release its earnings on Nov 6, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription
    4 weeks ago
    -9.65%
    ADMA Biologics shares are trading lower after the ... Unlock content with Pro Subscription
    1 month ago
    -2.22%
    ADMA Biologics shares are trading lower after the company reported worse-than-expected Q2 revenue results and issued FY26 revenue guidance below estimates.
    news image

    3 days ago · seekingalpha.com

    ADMA Biologics: Strong Product Mix, Growing Margins And Compelling Upside

    ADMA Biologics' earnings are surging due to higher plasma yield and a profitable shift toward premium IG brands, boosting margins. FDA approval of yield-enhancement technology increases finished IG ou...

    news image

    3 weeks ago · seekingalpha.com

    ADMA Biologics: Optionality With SG-001 And A Vertically Integrated IG Platform

    ADMA's growth remains centered on Asceniv, Bivigam, and NABI-HB. These are its main value drivers today. ADMA Biologics' recent Q2 report showed that the company is working on enhancing its plasma yie...

    news image

    4 weeks ago · seekingalpha.com

    ADMA Biologics: A Better Quarter Than Headline Numbers

    ADMA Biologics experienced a significant stock pullback on Thursday after Q2 results, presenting a potential buying opportunity for investors. The company now operates 10 plasma collection centers and...

    news image

    4 weeks ago · zacks.com

    ADMA Beats on Q2 Earnings and Revenues, Asceniv Drives Momentum

    ADMA Biologics' Q2 earnings and revenue beat can be attributed to Asceniv growth. However, shares fall 7.4% in after-hours trading.

    news image

    1 month ago · fool.com

    Adma Biologics (ADMA) Q2 Revenue Up 14%

    Adma Biologics (ADMA) Q2 Revenue Up 14%

    news image

    1 month ago · seekingalpha.com

    ADMA Biologics, Inc. (ADMA) Q2 2025 Earnings Call Transcript

    ADMA Biologics, Inc. (NASDAQ:ADMA ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Adam S. Grossman - Co-Founder, President, CEO & Director Brad Tade - CFO & Treasurer...

    news image

    1 month ago · zacks.com

    Adma Biologics (ADMA) Q2 Earnings and Revenues Beat Estimates

    Adma Biologics (ADMA) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.13 per share a year ago.

    news image

    1 month ago · zacks.com

    Adma Biologics (ADMA) Ascends While Market Falls: Some Facts to Note

    In the latest trading session, Adma Biologics (ADMA) closed at $18.59, marking a +1.81% move from the previous day.

    news image

    1 month ago · zacks.com

    Adma Biologics (ADMA) Rises As Market Takes a Dip: Key Facts

    The latest trading day saw Adma Biologics (ADMA) settling at $18.26, representing a +1.44% change from its previous close.

    news image

    1 month ago · zacks.com

    Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet

    Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe...

    Add to Watchlist